The companion diagnostic was once a niche sidekick in oncology, a modest tool for identifying the right patients for a small ...
COVID-19 TESTING LABORATORY SUBSIDIARIES FILE FOR BANKRUPCTY PROTECTION UNIONDALE, NY, Sept (GLOBE NEWSWIRE) -- ProPhase Labs, Inc.
The seven chimeric antigen receptor T-cell therapies approved in the United States have revolutionized treatment of blood cancers.Eight years after the first CAR-T product entered the market, members ...
The volatile biotech industry has done reasonably well so far in 2025 amid the ongoing tariff saga. Most pharma/biotech bigwigs are now investing heavily in manufacturing plants/operations in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback